chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Pain in extremity, Pain in jaw, Toothache
Clinical narrative: Arm was really sore; Headache; teeth hurt; Jaw started to get sore; couldn't sleep because her head hurt so bad; A spontaneous report was received from a consumer concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was really sore, headache, jaw started to get sore, teeth hurt, couldn't sleep because her head hurt so bad.  The patient's medical history include hyperlipidemia, hypertension and prediabetic. Concomitant medications reported were diltiazem, hydrochlorothiazide, potassium, omeprazole, cinnamon, metformin for drug use for unknown indication.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) in the left arm for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the events arm was really sore. headache, jaw started to get sore, teeth hurt,  couldn't sleep because her head hurt so bad.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, arm was really sore, headache,jaw started to get sore,teeth hurt,couldn't sleep because her head hurt so bad was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vaccination site pain, Vomiting
Clinical narrative: sore arm; chills; nausea; vomiting; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown and CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: 3X5cm pink itchy area near the injection site (Left arm); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 02-Feb-2021.    This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PRURITUS (3X5cm pink itchy area near the injection site (Left arm)) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INJECTION SITE PRURITUS (3X5cm pink itchy area near the injection site (Left arm)). At the time of the report, INJECTION SITE PRURITUS (3X5cm pink itchy area near the injection site (Left arm)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Concomitant medication  was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Fatigue, Nasal congestion, Pain in extremity
Clinical narrative: This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS) and RASH ERYTHEMATOUS (RED RASH on back and chest) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS), RASH ERYTHEMATOUS (RED RASH on back and chest), PYREXIA (MILD FEVER), FATIGUE (EXTREME FATIGUE) and PAIN IN EXTREMITY (Left arm sore if lifted). At the time of the report, SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS), RASH ERYTHEMATOUS (RED RASH on back and chest), PYREXIA (MILD FEVER), FATIGUE (EXTREME FATIGUE) and PAIN IN EXTREMITY (Left arm sore if lifted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash erythematous, Sneezing
Clinical narrative: This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS) and RASH ERYTHEMATOUS (RED RASH on back and chest) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS), RASH ERYTHEMATOUS (RED RASH on back and chest), PYREXIA (MILD FEVER), FATIGUE (EXTREME FATIGUE) and PAIN IN EXTREMITY (Left arm sore if lifted). At the time of the report, SNEEZING (FREQUENT SNEEZING), COUGH (COUGHING), NASAL CONGESTION (INTENSE CONGESTION), DIZZINESS (DIZZINESS), RASH ERYTHEMATOUS (RED RASH on back and chest), PYREXIA (MILD FEVER), FATIGUE (EXTREME FATIGUE) and PAIN IN EXTREMITY (Left arm sore if lifted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site pruritus, Pain, Tenderness
Clinical narrative: it was sore first; his scalp and head were tender; his scalp and head were sore; he had a headache; it (injection site) started to itch; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (it (injection site) started to itch), INJECTION SITE PAIN (it was sore first), TENDERNESS (his scalp and head were tender), PAIN (his scalp and head were sore) and HEADACHE (he had a headache) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. None) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced INJECTION SITE PRURITUS (it (injection site) started to itch). On an unknown date, the patient experienced INJECTION SITE PAIN (it was sore first), TENDERNESS (his scalp and head were tender), PAIN (his scalp and head were sore) and HEADACHE (he had a headache). At the time of the report, INJECTION SITE PRURITUS (it (injection site) started to itch), INJECTION SITE PAIN (it was sore first), TENDERNESS (his scalp and head were tender), PAIN (his scalp and head were sore) and HEADACHE (he had a headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes advil for headache.   Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Red area on her right jaw that was very itchy; Red area on her right jaw that was very itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red area on her right jaw that was very itchy) and PRURITUS (Red area on her right jaw that was very itchy) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced ERYTHEMA (Red area on her right jaw that was very itchy) and PRURITUS (Red area on her right jaw that was very itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg. At the time of the report, ERYTHEMA (Red area on her right jaw that was very itchy) and PRURITUS (Red area on her right jaw that was very itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. The event occurred one hour after the vaccination.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Ear discomfort, Limb discomfort, Lymphadenopathy, Rhinorrhoea
Clinical narrative: Swollen left lymph node on the bottom of her neck, right above the clavicle; Runny nose; Left ear felt a little blocked; Pain higher above her heart; Arm discomfort; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of LIMB DISCOMFORT (Arm discomfort), CHEST PAIN (Pain higher above her heart), LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced LIMB DISCOMFORT (Arm discomfort). On 13-Jan-2021, the patient experienced CHEST PAIN (Pain higher above her heart). On 17-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked). The patient was treated with NAPROXEN at an unspecified dose and frequency and MULTIVITAMINS [VITAMINS NOS] at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (Arm discomfort), CHEST PAIN (Pain higher above her heart), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked) outcome was unknown and LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Multivitamins and Prilazac or Naproxen.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Swollen left lymph node on the bottom of her neck, right above the clavicle; Runny nose; Left ear felt a little blocked; Pain higher above her heart; Arm discomfort; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of LIMB DISCOMFORT (Arm discomfort), CHEST PAIN (Pain higher above her heart), LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced LIMB DISCOMFORT (Arm discomfort). On 13-Jan-2021, the patient experienced CHEST PAIN (Pain higher above her heart). On 17-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked). The patient was treated with NAPROXEN at an unspecified dose and frequency and MULTIVITAMINS [VITAMINS NOS] at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (Arm discomfort), CHEST PAIN (Pain higher above her heart), RHINORRHOEA (Runny nose) and EAR DISCOMFORT (Left ear felt a little blocked) outcome was unknown and LYMPHADENOPATHY (Swollen left lymph node on the bottom of her neck, right above the clavicle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Multivitamins and Prilazac or Naproxen.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Flatulence, Headache
Clinical narrative: Had a lot of gas; Developed a rash on the back of her neck and shoulders, as well as both arms; Dizzy; was terrible sick; fever; joint pain; muscle pain; fatigue; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 02-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), ILLNESS (was terrible sick), FLATULENCE (Had a lot of gas), PYREXIA (fever) and ARTHRALGIA (joint pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) for an unknown indication, IBUPROFEN (ADVIL 12 HOUR).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DIZZINESS (Dizzy), ILLNESS (was terrible sick), PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue) and HEADACHE (headache). On an unknown date, the patient experienced FLATULENCE (Had a lot of gas) and RASH (Developed a rash on the back of her neck and shoulders, as well as both arms). At the time of the report, DIZZINESS (Dizzy), ILLNESS (was terrible sick), FLATULENCE (Had a lot of gas), PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), HEADACHE (headache) and RASH (Developed a rash on the back of her neck and shoulders, as well as both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes antihistamine and Advil.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Pyrexia, Rash
Clinical narrative: Had a lot of gas; Developed a rash on the back of her neck and shoulders, as well as both arms; Dizzy; was terrible sick; fever; joint pain; muscle pain; fatigue; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to Moderna on 02-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), ILLNESS (was terrible sick), FLATULENCE (Had a lot of gas), PYREXIA (fever) and ARTHRALGIA (joint pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) for an unknown indication, IBUPROFEN (ADVIL 12 HOUR).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DIZZINESS (Dizzy), ILLNESS (was terrible sick), PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue) and HEADACHE (headache). On an unknown date, the patient experienced FLATULENCE (Had a lot of gas) and RASH (Developed a rash on the back of her neck and shoulders, as well as both arms). At the time of the report, DIZZINESS (Dizzy), ILLNESS (was terrible sick), FLATULENCE (Had a lot of gas), PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), HEADACHE (headache) and RASH (Developed a rash on the back of her neck and shoulders, as well as both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes antihistamine and Advil.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Myalgia
Clinical narrative: diarrhea; chills; body aches; shortness of breath, when she woke up in the morning; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath, when she woke up in the morning), DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DYSPNOEA (shortness of breath, when she woke up in the morning). On 02-Feb-2021, the patient experienced DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches). On 01-Feb-2021, DYSPNOEA (shortness of breath, when she woke up in the morning) outcome was unknown. At the time of the report, DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes Tylenol for diarrhea. Concomitant medication for depression and anxiety.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Injection site erythema, Paraesthesia oral
Clinical narrative: Lip tingling; numb lips/tongue numbness; injection site redness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Lip tingling), HYPOAESTHESIA ORAL (numb lips/tongue numbness) and INJECTION SITE ERYTHEMA (injection site redness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PARAESTHESIA ORAL (Lip tingling), HYPOAESTHESIA ORAL (numb lips/tongue numbness) and INJECTION SITE ERYTHEMA (injection site redness). At the time of the report, PARAESTHESIA ORAL (Lip tingling), HYPOAESTHESIA ORAL (numb lips/tongue numbness) and INJECTION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Benadryl. Concomitant medication was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Still hot at the site; At the site it is still red, a circle of 2.5 inches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Still hot at the site) and VACCINATION SITE ERYTHEMA (At the site it is still red, a circle of 2.5 inches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, HYDROCHLOROTHIAZIDE, HYDROXYZINE and PANTOPRAZOLE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Still hot at the site) and VACCINATION SITE ERYTHEMA (At the site it is still red, a circle of 2.5 inches). At the time of the report, VACCINATION SITE WARMTH (Still hot at the site) and VACCINATION SITE ERYTHEMA (At the site it is still red, a circle of 2.5 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not use any treatment medication.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 83.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: arm became red; arm became itchy; arm became swollen; Hurting injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Feb-2021 and was forwarded to the company on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm became red), VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE SWELLING (arm became swollen) and VACCINATION SITE PAIN (Hurting injection site) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042Z20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included HCTZ and LOSARTAN for Blood pressure.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm became red), VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE SWELLING (arm became swollen) and VACCINATION SITE PAIN (Hurting injection site). At the time of the report, VACCINATION SITE ERYTHEMA (arm became red), VACCINATION SITE PRURITUS (arm became itchy), VACCINATION SITE SWELLING (arm became swollen) and VACCINATION SITE PAIN (Hurting injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included hydrocortisone cream and cefalexin as well, for a toe infection.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash, Vaccination site urticaria
Clinical narrative: rash came back but this time it was more of 2 or 3 inch in circle that started to appear outside of the site of the injection; swelling underneath arm; rash (bright red) look alike rash that was size of quarter; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling underneath arm), RASH (rash (bright red) look alike rash that was size of quarter), PRURITUS (Itching) and VACCINATION SITE URTICARIA (rash came back but this time it was more of 2 or 3 inch in circle that started to appear outside of the site of the injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concomitant products included LORATADINE for Allergy, FAMOTIDINE, LOSARTAN, MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (swelling underneath arm), RASH (rash (bright red) look alike rash that was size of quarter) and PRURITUS (Itching). On 31-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (rash came back but this time it was more of 2 or 3 inch in circle that started to appear outside of the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL CHILDRENS) for Vaccination site reaction, at a dose of 25 mg; PARACETAMOL (TYLENOL) on 22-Jan-2021 for Vaccination site reaction, at a dose of 500 mg once and LORATADINE (CLARITINE) for Vaccination site reaction, at a dose of 10 mg. On 25-Jan-2021, PERIPHERAL SWELLING (swelling underneath arm), RASH (rash (bright red) look alike rash that was size of quarter) and PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE URTICARIA (rash came back but this time it was more of 2 or 3 inch in circle that started to appear outside of the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Nausea
Clinical narrative: Chills; headache; body ache, muscle pain; joint pain; fever; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 16-Jan-2021.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain), PYREXIA (fever) and NAUSEA (nauseas). At the time of the report, CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain), PYREXIA (fever) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; headache; body ache, muscle pain; joint pain; fever; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 16-Jan-2021.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain), PYREXIA (fever) and NAUSEA (nauseas). At the time of the report, CHILLS (Chills), HEADACHE (headache), MYALGIA (body ache, muscle pain), ARTHRALGIA (joint pain), PYREXIA (fever) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Epistaxis, Injection site erythema, Injection site pruritus, Limb discomfort, Vaccination site induration
Clinical narrative: burning; very uncomfortable arm.; wheezing; whenever she blow nose is bloody; itching at the site of injection; redness at the site which is spreading and looks like hives; area of arm at injection site is hard to touch; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody) and INJECTION SITE PRURITUS (itching at the site of injection) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody), INJECTION SITE PRURITUS (itching at the site of injection), INJECTION SITE ERYTHEMA (redness at the site which is spreading and looks like hives) and VACCINATION SITE INDURATION (area of arm at injection site is hard to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody), INJECTION SITE PRURITUS (itching at the site of injection), INJECTION SITE ERYTHEMA (redness at the site which is spreading and looks like hives) and VACCINATION SITE INDURATION (area of arm at injection site is hard to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    Reporter did not allow further contact
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain, Wheezing
Clinical narrative: burning; very uncomfortable arm.; wheezing; whenever she blow nose is bloody; itching at the site of injection; redness at the site which is spreading and looks like hives; area of arm at injection site is hard to touch; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody) and INJECTION SITE PRURITUS (itching at the site of injection) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody), INJECTION SITE PRURITUS (itching at the site of injection), INJECTION SITE ERYTHEMA (redness at the site which is spreading and looks like hives) and VACCINATION SITE INDURATION (area of arm at injection site is hard to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (burning), LIMB DISCOMFORT (very uncomfortable arm.), WHEEZING (wheezing), EPISTAXIS (whenever she blow nose is bloody), INJECTION SITE PRURITUS (itching at the site of injection), INJECTION SITE ERYTHEMA (redness at the site which is spreading and looks like hives) and VACCINATION SITE INDURATION (area of arm at injection site is hard to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L209) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, PANTOPRAZOLE, MELOXICAM and TAMSULOSIN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: .; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event of diarrhea, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm). At the time of the report, RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Her HCP recommended she does not receive the 2nd dose.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: dizzy spell; felt faint; woozy; very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (woozy), FATIGUE (very fatigued), DIZZINESS (felt faint) and DIZZINESS (dizzy spell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced DIZZINESS (woozy). In January 2021, the patient experienced FATIGUE (very fatigued). On 16-Jan-2021, the patient experienced DIZZINESS (felt faint). On 17-Jan-2021, the patient experienced DIZZINESS (dizzy spell). On 12-Jan-2021, DIZZINESS (woozy) had resolved. In January 2021, FATIGUE (very fatigued) had resolved. On 16-Jan-2021, DIZZINESS (felt faint) had resolved. On 17-Jan-2021, DIZZINESS (dizzy spell) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included UTI.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No new information received.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: A reaction; A spontaneous report was received from a consumer concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a reaction/adverse reaction.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch number: unknown) for prophylaxis of COVID-19 infection.  On an unknown date, the experienced a reaction. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event a reaction was not reported.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest discomfort, Dizziness, Fatigue, Headache
Clinical narrative: feels tense; anxiety; tired; felt like crap; slept for 2.5 hours; hot flashes; very dizzy /dizziness lasted 5 hours; became nauseated; headaches; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (arm was sore), HOT FLUSH (hot flashes), NAUSEA (became nauseated), DIZZINESS (very dizzy /dizziness lasted 5 hours) and HEADACHE (headaches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 38K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for High cholesterol, Essig monthly injection for Migraine, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, ALPRAZOLAM (XANAX) for Vertigo.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 29-Jan-2021, the patient experienced PAIN (arm was sore). On 31-Jan-2021, the patient experienced HOT FLUSH (hot flashes), NAUSEA (became nauseated), DIZZINESS (very dizzy /dizziness lasted 5 hours), HEADACHE (headaches), CHEST DISCOMFORT (felt like crap) and INSOMNIA (slept for 2.5 hours). On 01-Feb-2021, the patient experienced FATIGUE (tired), TENSION (feels tense) and ANXIETY (anxiety). On 31-Jan-2021, DIZZINESS (very dizzy /dizziness lasted 5 hours) had resolved. At the time of the report, PAIN (arm was sore), HOT FLUSH (hot flashes), NAUSEA (became nauseated), HEADACHE (headaches), FATIGUE (tired), TENSION (feels tense), ANXIETY (anxiety), CHEST DISCOMFORT (felt like crap) and INSOMNIA (slept for 2.5 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 31-Jan-2021 she reported she took a Xanax and went to bed.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Insomnia, Nausea, Pain, Tension
Clinical narrative: feels tense; anxiety; tired; felt like crap; slept for 2.5 hours; hot flashes; very dizzy /dizziness lasted 5 hours; became nauseated; headaches; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (arm was sore), HOT FLUSH (hot flashes), NAUSEA (became nauseated), DIZZINESS (very dizzy /dizziness lasted 5 hours) and HEADACHE (headaches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 38K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for High cholesterol, Essig monthly injection for Migraine, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, ALPRAZOLAM (XANAX) for Vertigo.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 29-Jan-2021, the patient experienced PAIN (arm was sore). On 31-Jan-2021, the patient experienced HOT FLUSH (hot flashes), NAUSEA (became nauseated), DIZZINESS (very dizzy /dizziness lasted 5 hours), HEADACHE (headaches), CHEST DISCOMFORT (felt like crap) and INSOMNIA (slept for 2.5 hours). On 01-Feb-2021, the patient experienced FATIGUE (tired), TENSION (feels tense) and ANXIETY (anxiety). On 31-Jan-2021, DIZZINESS (very dizzy /dizziness lasted 5 hours) had resolved. At the time of the report, PAIN (arm was sore), HOT FLUSH (hot flashes), NAUSEA (became nauseated), HEADACHE (headaches), FATIGUE (tired), TENSION (feels tense), ANXIETY (anxiety), CHEST DISCOMFORT (felt like crap) and INSOMNIA (slept for 2.5 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 31-Jan-2021 she reported she took a Xanax and went to bed.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: red; her arm is swollen,; very painful; hard to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (her arm is swollen,), VACCINATION SITE PAIN (very painful), VACCINATION SITE INDURATION (hard to touch) and VACCINATION SITE ERYTHEMA (red) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE SWELLING (her arm is swollen,), VACCINATION SITE PAIN (very painful) and VACCINATION SITE INDURATION (hard to touch). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE SWELLING (her arm is swollen,), VACCINATION SITE PAIN (very painful), VACCINATION SITE INDURATION (hard to touch) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: her arm is very achy; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MYALGIA (her arm is very achy ) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 29-Jan-2021, the patient experienced MYALGIA (her arm is very achy ). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Jan-2021, PAIN IN EXTREMITY (Sore arm) had not resolved. At the time of the report, MYALGIA (her arm is very achy ) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Reporter did not allow further contact